Resveratrol Is a Selective Human Cytochrome P450 1A1 Inhibitor

This publication has 28 references indexed in Scilit:

• Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrol
  British Journal of Pharmacology, 1999
• Prediction of Aryl Hydrocarbon Receptor-Mediated Enzyme Induction of Drugs and Chemicals by mRNA Quantification
  Chemical Research in Toxicology, 1998
• Resveratrol Arrests the Cell Division Cycle at S/G2 Phase Transition
  Biochemical and Biophysical Research Communications, 1998
• Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests
  Life Sciences, 1997
• Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
  Science, 1997
• Aryl Acetylenes as Mechanism-Based Inhibitors of Cytochrome P450-Dependent Monooxygenase Enzymes
  Chemical Research in Toxicology, 1997
• Method To Assay the Concentrations of Phenolic Constituents of Biological Interest in Wines
  Analytical Chemistry, 1996
• Inhibition of human LDL oxidation by resveratrol
  The Lancet, 1993
• Effects of stilbenes on arachidonate metabolism in leukocytes
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
• The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury
  Physiological Plant Pathology, 1976